Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO)

Market Closed
11 Jul, 20:00
NYSE NYSE
$
434. 86
+4.13
+0.96%
$
158.06B Market Cap
37.17 P/E Ratio
1.56% Div Yield
2,511,400 Volume
21.53 Eps
$ 430.73
Previous Close
Day Range
425.65 436.32
Year Range
385.46 627.88
Want to track TMO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 8 days
Thermo Fisher Scientific: Tariff And Policy Impacts Look Priced In

Thermo Fisher Scientific: Tariff And Policy Impacts Look Priced In

Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Thermo can mitigate the tariff issues by next year, as its scale gives it options to source from different locations. Despite short-term challenges, Thermo Fisher aims for 7-9% long-term sales growth, leveraging its diverse product range and strategic acquisitions.

Seekingalpha | 2 months ago
Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up

Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up

TMO continues to advance its growth strategy and trusted partner status with customers in the first quarter of 2025.

Zacks | 2 months ago
Thermo Fisher Tops Q1 Estimates in 'Uncertain Macroeconomic Environment'

Thermo Fisher Tops Q1 Estimates in 'Uncertain Macroeconomic Environment'

Thermo Fisher Scientific (TMO) shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter results above analysts' expectations.

Investopedia | 2 months ago
Thermo Fisher Scientific Inc. (TMO) Q1 2025 Earnings Call Transcript

Thermo Fisher Scientific Inc. (TMO) Q1 2025 Earnings Call Transcript

Thermo Fisher Scientific Inc. (NYSE:TMO ) Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief Executive Officer Stephen Williamson - Senior Vice President & Chief Financial Officer Conference Call Participants Michael Ryskin - Bank of America Matt Sykes - Goldman Sachs Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Doug Schenkel - Wolfe Research Tycho Peterson - Jefferies Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 First Quarter Conference Call. [Operator Instructions] I would like to introduce our moderator for the call, Mr.

Seekingalpha | 2 months ago
Thermo Fisher (TMO) Reports Q1 Earnings: What Key Metrics Have to Say

Thermo Fisher (TMO) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 2 months ago
Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Beat Estimates

Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Beat Estimates

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.15 per share, beating the Zacks Consensus Estimate of $5.10 per share. This compares to earnings of $5.11 per share a year ago.

Zacks | 2 months ago
Stay Ahead of the Game With Thermo Fisher (TMO) Q1 Earnings: Wall Street's Insights on Key Metrics

Stay Ahead of the Game With Thermo Fisher (TMO) Q1 Earnings: Wall Street's Insights on Key Metrics

Get a deeper insight into the potential performance of Thermo Fisher (TMO) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 2 months ago
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for

Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
Thermo Fisher Scientific And Its Real Value

Thermo Fisher Scientific And Its Real Value

Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a viable long-term investment. TMO's recent product expansion, including the breakthrough Krios 5 Cryo-TEM technology, is expected to drive future growth and support earnings. Valuation metrics indicate TMO is currently undervalued.

Seekingalpha | 3 months ago
Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now?

Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now?

TMO continues to hold on to investors' attention due to its value-added acquisitions and trusted end-market channels.

Zacks | 3 months ago
Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock

Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock

TMO and CZ Imaging Institute to collaborate on further understanding of human cells.

Zacks | 3 months ago
TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab

TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab

Thermo Fisher introduces the Vulcan Automated Lab to transform semiconductor analysis.

Zacks | 3 months ago
Loading...
Load More